Background: The glycosaminoglycan HS is attached to
the core proteins of HS proteoglycans (HSPGs). HS is strongly expressed in
islets in situ and plays a critical role in beta cell survival.
Objective: This study
examined the potential mechanism for the depletion of intra-islet HS during
islet isolation.
Methods: HSPGs (collagen
type XVIII, syndecan-1) and HS in B6 and B6.Hpse-KO (lacking the HS-degrading
enzyme heparanase (Hpse)) islets pre- and post-isolation were examined by
immunohistochemistry and Alcian blue histochemistry, respectively. Donor mice
were treated with hydroethidine (80 nmol/kg i.v.) to identify oxidation
products in extracts of isolated islets by liquid chromatography/ mass
spectrometry. Isolated beta cells ± culture with 50 μg/ml heparin were examined for
intracellular oxidants e.g., reactive oxygen species, using dihydrodichlorofluorescein diacetate (H2DCFDA) and flow cytometry. Additional
donor mice were treated with the antioxidant butylated hydroxyanisole (BHA, 120 mg/kg i.p.) and the antioxidant dimethylthiourea
(DMTU, 50 mM) was included in the isolation process.
Results: Islets pre- and post-isolation
showed intense expression of collagen type XVIII and syndecan-1 core proteins.
In contrast, B6 and B6.Hpse-KO isolated islets showed 50%-60% loss of
intra-islet HS. Superoxide and non-specific oxidation products were identified
in islet extracts. DCF-derived fluorescence (identifying oxidants) was detected in control isolated beta cells but not
following HS replacement with heparin. Antioxidant treatment significantly
improved the HS content of isolated islets.
Conclusions: These findings suggest that
loss of islet HS during islet isolation is due to oxidant-mediated
degradation and not to Hpse or loss of HSPG core proteins. HS replacement in
beta cells prevented detection of DCF-derived fluorescence, suggesting that in
situ beta cell HS may function as an antioxidant. Our findings indicate that
during islet isolation, excessive levels of oxidants are generated,
damaging beta cell HS. We propose that HS
deficiency leads to poor islet viability and islet loss after transplantation.